ADGM

Adagio Medical Holdings

ADGM

Attention (50-day avg)0%

Attention rank (50-day avg)#2,769

Bullish sentiment (50-day avg)69%

Price to earnings ratio-0.11

Market capitalization3.8M

Earnings per share-1.37

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)-25.1M

Social

What share of all stock conversation is about ADGM?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% +0	0% 0	0% 0

Sep 24

Adagio Medical Holdings, Inc. (ADGM) has initiated a strategic review of its business and will lay off more than half its full-time workers due to facing delisting on the Nasdaq exchange.
The company is exploring options for a merger, corporate acquisition, or outright asset sale, with some analysts suggesting a major medical device player could buy out Adagio for its ULTA patent portfolio.
Adagio's management and ownership structure have been called into question, with a hedge fund owning 50% of the company and its board of directors including a managing director for the hedge fund, raising concerns about potential conflicts of interest.

Generated by AI

Sentiment

Of the messages about ADGM that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	0%	52.38%	52.38% -18.56	69.22% -10.41
Bearish	100%	47.62%	47.62% +18.56	30.78% +10.41

Bullish· Aug 4

The company has seen a significant price increase, with the stock surging 35% in premarket due to the FDA's green light for the execution of the first patient treatment with the next-gen vCLAS Ultra ULTA system.
The biotech sector is particularly active, with Adagio Medical Holdings, Inc. (ADGM) moving faster than other companies in the sector, creating opportunities for further growth.
With a strong price action and a potential 5X increase from the current value, the company could still be undervalued, making it an attractive investment opportunity.

Bearish· Aug 4

The company's stock price has broken below key levels, with some users predicting further decline to $1.
The stock's performance has been erratic, with users experiencing significant losses, and some are unable to hold onto gains.
There is a perceived risk of dilution, which some users believe could negatively impact the stock's value.

Generated by AI

Topics

Of the messages about ADGM that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	81.25%	81.25%	51.93%
Technical Analysis	—	6.25%	6.25%	27.72%
Macro	—	0%	0%	13.33%
Controversies	—	12.5%	12.5%	1.4%
Analysts	—	0%	0%	2.46%
Earnings	—	0%	0%	3.16%

Aug 4

$ADGM is showing a downtrend breakout with a target of $1.55 and a strong volume increase.
The stock needs to stay above $0.85 to maintain its bullish structure, and a reclaim of $1.00 is possible with a push toward filling the gap.
$ADGM has formed a cup and handle pattern on the 5-minute chart, and a breakout above $1.06 could lead to a push toward $1.20+.

Generated by AI

Community

Of the messages about ADGM, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	21.05%	25.3%	18.28%
Newcomers	0%	78.95%	74.7%	81.72%

Regulars· Aug 4

The company's price has had significant gains, with one post mentioning a 131% increase from $0.48 to $1.11.
There is an FDA application in progress, which one post suggests could lead to the company's value increasing 5 times its current value and still be undervalued.
The post with the highest level of detail about the company's price action mentions a 120% increase from $0.48 to $1.06.

Newcomers· Sep 24

The newcomers are focused on Adagio's (ADGM) technology being outdated and not worth investing in, with one user stating it's an "obsolete technology" and another mentioning it's not worth selling.
Some newcomers believe Adagio's tech has clear value and that a major medical device player could acquire the company, offering a premium on the stock price.
The newcomers are also concerned about Adagio's upcoming compliance plan and potential risk of delisting, with one user mentioning the need for a compliance plan by September 28th.

Generated by AI

News

Adagio Medical Initiates Strategic Review and Workforce Reduction While Advancing vCLAS PMA

Adagio Medical (NASDAQ:ADGM) has begun a formal strategic review that could include a sale, merger or other transaction, while reducing its workforce and continuing to advance the U. S.

6d agoYahoo Finance

Adagio Medical explores strategic alternatives, cuts workforce

6d agoInvesting.com

Adagio Medical enrolls first patient in vCLAS Ultra study

13d agoInvesting.com

Adagio Medical Reports Second Quarter 2026 Results

LAGUNA HILLS, Calif., August 11, 2026--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the second quarter ended June 30, 2026.

1mo agoYahoo Finance

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Bluejay Diagnostics (NASDAQ:BJDX), Estre

Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 43.0% to $1.43 during Wednesday's pre-market session. The company's market cap stands at $1.0 million. Estrella Immunopharma (NASDAQ:ESLA)

1mo agoBenzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session - Autonomix Medical (NASDAQ:AMIX), Adagio Medi

Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 415.3% to $18.81 during Tuesday's regular session. The company's market cap stands at $1.9 million. Adagio Medical Holdings (NASDAQ:ADGM) shares increased by

1mo agoBenzinga

Also Discussed

Investors talking about ADGM also mention

#	Name	Attention
1	Nocera, Inc.NCRA	0%new
2	TNL Mediagene Ordinary SharesTNMG	0%new
3	MKDWELL Tech Inc.MKDW	0%+0
4	GlucoTrack Inc.GCTK	0%0
5	Mangoceuticals, Inc.MGRX	0%0
6	Zhongchao Inc. Class A Ordinary SharesZCMD	0%new
7	Bluejay Diagnostics Inc.BJDX	0%0
8	Advanced Biomed Inc.ADVB	0%0
9	Autonomix Medical Inc.AMIX	0%0
10	ProMIS Neurosciences Inc.PMN	0%0

Adagio Medical Holdings, Inc.

Healthcare
Medical Devices

Adagio Medical Holdings, Inc. is a medical technology company focused on developing and commercializing catheter-based ablation systems for the treatment of cardiac arrhythmias. Its current portfolio includes the iCLAS atrial ultra-low temperature ablation system, the vCLAS ventricular ultra-low temperature catheter platform, and Cryopulse pulsed field cryoablation catheters. These technologies are designed to support physicians treating rhythm disorders such as atrial fibrillation and ventricular tachycardia, with an emphasis on delivering targeted lesion creation in cardiac tissue. Adagio Medical Holdings, Inc. operates as a healthcare device company serving the electrophysiology market, where catheter ablation plays an important role in minimally invasive heart rhythm management. Headquartered in Laguna Hills, California, the company concentrates on clinical and commercial use cases across cardiac arrhythmia care.

Website

Location

26051 Merit Circle

Laguna Hills, CA, 92653

United States

Social

What share of all stock conversation is about ADGM?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% +0	0% 0	0% 0

Sep 24

Adagio Medical Holdings, Inc. (ADGM) has initiated a strategic review of its business and will lay off more than half its full-time workers due to facing delisting on the Nasdaq exchange.
The company is exploring options for a merger, corporate acquisition, or outright asset sale, with some analysts suggesting a major medical device player could buy out Adagio for its ULTA patent portfolio.
Adagio's management and ownership structure have been called into question, with a hedge fund owning 50% of the company and its board of directors including a managing director for the hedge fund, raising concerns about potential conflicts of interest.

Generated by AI

Sentiment

Of the messages about ADGM that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	0%	52.38%	52.38% -18.56	69.22% -10.41
Bearish	100%	47.62%	47.62% +18.56	30.78% +10.41

Bullish· Aug 4

The company has seen a significant price increase, with the stock surging 35% in premarket due to the FDA's green light for the execution of the first patient treatment with the next-gen vCLAS Ultra ULTA system.
The biotech sector is particularly active, with Adagio Medical Holdings, Inc. (ADGM) moving faster than other companies in the sector, creating opportunities for further growth.
With a strong price action and a potential 5X increase from the current value, the company could still be undervalued, making it an attractive investment opportunity.

Bearish· Aug 4

The company's stock price has broken below key levels, with some users predicting further decline to $1.
The stock's performance has been erratic, with users experiencing significant losses, and some are unable to hold onto gains.
There is a perceived risk of dilution, which some users believe could negatively impact the stock's value.

Generated by AI

Topics

Of the messages about ADGM that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	81.25%	81.25%	51.93%
Technical Analysis	—	6.25%	6.25%	27.72%
Macro	—	0%	0%	13.33%
Controversies	—	12.5%	12.5%	1.4%
Analysts	—	0%	0%	2.46%
Earnings	—	0%	0%	3.16%

Aug 4

$ADGM is showing a downtrend breakout with a target of $1.55 and a strong volume increase.
The stock needs to stay above $0.85 to maintain its bullish structure, and a reclaim of $1.00 is possible with a push toward filling the gap.
$ADGM has formed a cup and handle pattern on the 5-minute chart, and a breakout above $1.06 could lead to a push toward $1.20+.

Generated by AI

Community

Of the messages about ADGM, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	21.05%	25.3%	18.28%
Newcomers	0%	78.95%	74.7%	81.72%

Regulars· Aug 4

The company's price has had significant gains, with one post mentioning a 131% increase from $0.48 to $1.11.
There is an FDA application in progress, which one post suggests could lead to the company's value increasing 5 times its current value and still be undervalued.
The post with the highest level of detail about the company's price action mentions a 120% increase from $0.48 to $1.06.

Newcomers· Sep 24

The newcomers are focused on Adagio's (ADGM) technology being outdated and not worth investing in, with one user stating it's an "obsolete technology" and another mentioning it's not worth selling.
Some newcomers believe Adagio's tech has clear value and that a major medical device player could acquire the company, offering a premium on the stock price.
The newcomers are also concerned about Adagio's upcoming compliance plan and potential risk of delisting, with one user mentioning the need for a compliance plan by September 28th.

Generated by AI

Adagio Medical Holdings

Social

Sep 24

Bullish· Aug 4

Bearish· Aug 4

Aug 4

Regulars· Aug 4

Newcomers· Sep 24

Adagio Medical Initiates Strategic Review and Workforce Reduction While Advancing vCLAS PMA

Adagio Medical explores strategic alternatives, cuts workforce

Adagio Medical enrolls first patient in vCLAS Ultra study

Adagio Medical Reports Second Quarter 2026 Results

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Bluejay Diagnostics (NASDAQ:BJDX), Estre

12 Health Care Stocks Moving In Tuesday's Intraday Session - Autonomix Medical (NASDAQ:AMIX), Adagio Medi

Also Discussed

Adagio Medical Holdings, Inc.

Company Information

Location

Adagio Medical Initiates Strategic Review and Workforce Reduction While Advancing vCLAS PMA

Adagio Medical explores strategic alternatives, cuts workforce

Adagio Medical enrolls first patient in vCLAS Ultra study

Adagio Medical Reports Second Quarter 2026 Results

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Bluejay Diagnostics (NASDAQ:BJDX), Estre

12 Health Care Stocks Moving In Tuesday's Intraday Session - Autonomix Medical (NASDAQ:AMIX), Adagio Medi

Also Discussed

Social

Sep 24

Bullish· Aug 4

Bearish· Aug 4

Aug 4

Regulars· Aug 4

Newcomers· Sep 24